Related Experiment Video

Updated: Aug 9, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

SRC gene expression in human cancer: the role of transcriptional activation

Scott M Dehm1, Keith Bonham

  • 1Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada. dehm.scott@mayo.edu

Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|April 3, 2004
PubMed

Insights

The SRC gene

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Human pp60c-Src (c-Src) is a nonreceptor tyrosine kinase crucial for cell signaling.
  • c-Src dysregulation is implicated in over 50% of human cancers, including colon, liver, lung, breast, and pancreas.
  • Understanding c-Src activation mechanisms is vital for cancer therapy development.

Purpose of the Study:

  • To investigate the mechanisms of c-Src activation in human cancer.
  • To explore the role of SRC gene transcription and mutations in cancer.
  • To examine the impact of histone deacetylase (HDAC) inhibitors on SRC transcription.

Main Methods:

  • Analysis of post-translational modifications affecting c-Src kinase activity.
  • Identification of activating SRC mutations in colon tumors.
  • Quantification of SRC gene transcription levels in cancer cell lines.
  • Assessment of HDAC inhibitor effects on SRC gene expression.

Main Results:

  • c-Src activation in cancer is linked to post-translational modifications and protein overexpression.
  • Activating SRC mutations are found in a subset of advanced colon tumors.
  • Elevated SRC transcription significantly contributes to c-Src activation in colon cancer.
  • HDAC inhibitors effectively repress SRC transcription across various cancer cell lines.

Conclusions:

  • Multiple mechanisms, including post-translational changes, mutations, and transcriptional upregulation, contribute to c-Src activation in cancer.
  • Targeting SRC transcription represents a potential therapeutic strategy.
  • HDAC inhibitors show promise for inhibiting SRC gene expression in cancer treatment.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets03:37

Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets

Published on: March 1, 2024

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...